Release Date: 28/10/11 10:38 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 869.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%